Скачать или смотреть UK regulators brief on AstraZeneca, Oxford vaccine

(30 Dec 2020) The UK's medicine regulatory body said on Wednesday a review of the approved Oxford-AstraZeneca vaccine had been "scientifically rigorous".
Speaking at a news briefing, the chief executive of Medicines and Healthcare products Regulatory Agency (MHRA) June Raine said "AstraZeneca has been approved for use in people aged 18 years and older, with two standard doses four to 12 weeks apart."
The chair of the Commission on Human Medicines Expert Working Group, Professor Munir Pirmohamed, who worked on the rolling review of the second vaccine. said it takes 22 days to get "partial immunity after the first dose".
Raine also updated guidance on the first approved vaccine, Pfizer-BioNTech, which has now been approved for use by pregnant women, women who are breastfeeding and anyone with food allergies or allergies to other medicines.
"Of course, anyone with a history of allergic reaction to this vaccine or its ingredients should not," the MHRA chief said.

Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Twitter:   / ap_archive  
Facebook:   / aparchives   ​​
Instagram:   / apnews  


You can license this story through AP Archive: http://www.aparchive.com/metadata/you...